Atlas Trials

Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium

Clinical trial NCT06073184 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06073184
Sponsor
University Health Network, Toronto
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial CancerAtypical Hyperplasia
Start date
2025-08-01
Primary completion
2027-02-01
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.